VivoSim Labs, INC.
For the period ended Mar 31, 2026. Filed Jul 14, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed Jul 14, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Power of Attorney (included on signature page hereto)
SIGNAT URES
Pursuant to the requirements of the Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
| VIVOSIM LABS, INC. | |
| By: | /s/ Keith Murphy |
| Keith Murphy | |
| Executive Chairman | |
| Date: | July 14, 2026 |
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Keith Murphy and Norman Staskey, and each of them individually, as the undersigned’s true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for the undersigned and in the undersigned’s name, place, and stead, in any and all capacities, to sign any and all amendments to this Report, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as the undersigned might or could do in person, hereby ratifying and confirming that all said attorneys-in-fact and agents, or any of them or their respective substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ Keith Murphy | Executive Chairman | July 14, 2026 |
| Keith Murphy | (Principal Executive Officer) | |
| /s/ Norman Staskey | Chief Financial Officer | July 14, 2026 |
| Norman Staskey | (Principal Financial and Principal Accounting Officer) | |
| /s/ Adam Stern | Director | July 14, 2026 |
| Adam Stern | ||
| /s/ Douglas Cohen | Director | July 14, 2026 |
| Douglas Cohen | ||
| /s/ David Gobel | Director | July 14, 2026 |
| David Gobel | ||
| /s/ Alison Milhous | Director | July 14, 2026 |
| Alison Milhous | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.